LifeMD, Inc.·4

Jan 5, 10:41 AM ET

FRIEDEMAN JESSICA 4

4 · LifeMD, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
FRIEDEMAN JESSICA
Chief Marketing Officer
Transactions
  • Award

    Common Stock

    2023-01-03+150,000150,000 total
Footnotes (1)
  • [F1]Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 150,000 restricted shares, with 50,000 vesting on January 3, 2024, 50,000 vesting on January 3, 2025 and 50,000 vesting on January 3, 2026.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT